{"id":57991,"date":"2024-02-27T18:11:21","date_gmt":"2024-02-27T18:11:21","guid":{"rendered":"https:\/\/medsname.com\/lamivir\/"},"modified":"2026-05-16T05:24:27","modified_gmt":"2026-05-16T05:24:27","slug":"lamivir","status":"publish","type":"product","link":"https:\/\/medsbase.com\/hu\/product\/lamivir\/","title":{"rendered":"Lamivir"},"content":{"rendered":"
\n

Gyors v\u00e1lasz<\/h3>\n

Lamivir<\/strong> szakorvos \u00e1ltal fel\u00fcgyelt antiretrovir\u00e1lis ter\u00e1pia, amely a kombin\u00e1lt HIV-kezel\u00e9s r\u00e9szek\u00e9nt haszn\u00e1lhat\u00f3. A haszn\u00e1lat el\u0151tt olvassa el az adagol\u00e1si, mell\u00e9khat\u00e1si \u00e9s interakci\u00f3s r\u00e9szeket; a gyakran ism\u00e9telt k\u00e9rd\u00e9sek a lap alj\u00e1n tal\u00e1lhat\u00f3k.<\/p>\n<\/div>\n

\nMit kapsz a MedsBase-n\u00e1l:<\/strong> WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3 \u00b7 Diszkr\u00e9t csomagol\u00e1s \u00b7 Vil\u00e1gszerte sz\u00e1ll\u00edt\u00e1s \u00b7 1.400+ hiteles\u00edtett v\u00e1s\u00e1rl\u00f3i v\u00e9lem\u00e9ny<\/a>\n<\/div>\n

\ud83d\udce6 Minden rendel\u00e9st fedez a \u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n

Mi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n

Generikus gy\u00f3gyszereink WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3kt\u00f3l sz\u00e1rmaznak, \u00e9s diszkr\u00e9t, egyszer\u0171 csomagol\u00e1sban sz\u00e1ll\u00edtjuk \u0151ket vil\u00e1gszerte \u2014 a csomagon nem szerepel a gy\u00f3gyszer neve. A k\u00e1rty\u00e1s fizet\u00e9sek egy szab\u00e1lyozott feldolgoz\u00f3n kereszt\u00fcl t\u00f6rt\u00e9nnek (a sz\u00e1mlale\u00edr\u00e1sok egy szab\u00e1lyozott k\u00e1rtyafizet\u00e9si feldolgoz\u00f3t tartalmaznak \u2014 soha nem \u201cMedsBase\u201d vagy b\u00e1rmilyen gy\u00f3gyszer neve). Kriptovalut\u00e1t \u00e9s SEPA banki \u00e1tutal\u00e1st is elfogadunk. Minden rendel\u00e9st a Reshipment Assurance Policy biztos\u00edt\u00e9k fedez.<\/p>\n

Term\u00e9k \u00e1ttekint\u00e9s<\/strong><\/p>\n

Lamivir is a medication containing the active ingredient Lamivudine. It belongs to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs), which are used in the treatment of HIV (human immunodeficiency virus) infection. Lamivir works by inhibiting the replication of HIV, thereby slowing down the progression of the disease and reducing the risk of developing complications associated with HIV\/AIDS. This medication is available in various formulations, including tablets and oral solutions, to accommodate different patient needs and preferences.<\/p>\n

Haszn\u00e1lat<\/strong><\/p>\n

Lamivir is primarily used in the treatment of HIV infection, both in adults and children. It is often prescribed as part of a combination therapy regimen, which typically includes other antiretroviral medications. By inhibiting the replication of HIV, Lamivir helps to suppress the virus and maintain low levels of viral load in the bloodstream. This reduces the risk of HIV-related complications, improves immune function, and prolongs overall survival in HIV-infected individuals.<\/p>\n

Haszn\u00e1lati \u00fatmutat\u00f3<\/strong><\/p>\n

Lamivir tablets should be taken orally with or without food, as directed by your healthcare provider. It is important to take Lamivir regularly and exactly as prescribed to achieve optimal treatment outcomes. Do not skip doses or stop taking Lamivir without consulting your healthcare provider, as this can lead to the development of drug-resistant strains of HIV. If you are using Lamivir oral solution, carefully measure the prescribed dose using a dosing syringe or spoon provided with the medication.<\/p>\n

M\u0171k\u00f6d\u00e9s<\/strong><\/p>\n

Lamivir contains Lamivudine, which is a synthetic nucleoside analogue of cytidine. Once inside the body, Lamivudine is phosphorylated by cellular enzymes to its active form, Lamivudine triphosphate. This active metabolite competes with the natural substrate, deoxycytidine triphosphate, for incorporation into the viral DNA chain by the HIV reverse transcriptase enzyme. By incorporating into the growing viral DNA chain, Lamivudine terminates the DNA chain, preventing further viral replication and inhibiting the spread of HIV infection.<\/p>\n

Adagol\u00e1s \u00e9s alkalmaz\u00e1s<\/strong><\/p>\n

The dosage of Lamivir varies depending on factors such as the patient’s age, weight, renal function, and other medications being used. It is important to follow the dosage instructions provided by your healthcare provider. Typically, the recommended dose of Lamivir for adults and adolescents weighing at least 35 kg is 300 mg once daily or 150 mg twice daily. For pediatric patients, the dosage is based on body weight. Lamivir tablets should be swallowed whole with a glass of water and can be taken with or without food.<\/p>\n

El\u0151ny\u00f6k<\/strong><\/p>\n

The primary benefit of Lamivir is its effectiveness in suppressing HIV replication and reducing viral load in HIV-infected individuals. By controlling the progression of HIV infection, Lamivir helps to delay the onset of AIDS-related complications, improve immune function, and prolong overall survival. Additionally, Lamivir is generally well-tolerated and has a favorable safety profile when used as part of a comprehensive antiretroviral therapy regimen.<\/p>\n

Gyakori mell\u00e9khat\u00e1sok<\/strong><\/p>\n

Common side effects associated with Lamivir may include headache, nausea, vomiting, diarrhea, fatigue, and rash. These side effects are usually mild to moderate in severity and tend to improve over time as the body adjusts to the medication. However, if you experience severe or persistent side effects, contact your healthcare provider for further evaluation and management.<\/p>\n

Figyelmeztet\u00e9sek<\/strong><\/p>\n

Lamivir should be used with caution in patients with pre-existing renal impairment or hepatic dysfunction, as dosage adjustments may be necessary. It is important to inform your healthcare provider about any underlying medical conditions or medications you are taking before starting Lamivir therapy. Lamivir may interact with certain drugs, including other antiretroviral medications, so it is important to review your medication list with your healthcare provider to prevent potential drug interactions.<\/p>\n

T\u00e1rol\u00e1si inform\u00e1ci\u00f3k<\/strong><\/p>\n

Store Lamivir tablets at room temperature away from heat, moisture, and direct sunlight. Keep the medication out of reach of children and pets. Do not store Lamivir in the bathroom or kitchen, where it may be exposed to moisture or humidity. Proper storage helps maintain the stability and effectiveness of the medication throughout its shelf life.<\/p>\n

Jogi nyilatkozat:<\/strong><\/p>\n

Egyetlen sz\u00e1nd\u00e9kunk, hogy a fogyaszt\u00f3k szakmailag ellen\u0151rz\u00f6tt, pontos \u00e9s megb\u00edzhat\u00f3 inform\u00e1ci\u00f3kat kapjanak. Az itt tal\u00e1lhat\u00f3 inform\u00e1ci\u00f3kat azonban NEM szabad felhaszn\u00e1lni min\u0151s\u00edtett orvosi tan\u00e1cs helyettes\u00edt\u00e9s\u00e9re. Az itt k\u00f6z\u00f6lt inform\u00e1ci\u00f3k csak t\u00e1j\u00e9koztat\u00f3 jelleg\u0171ek. Lehet, hogy nem fedik le az \u00f6sszes lehets\u00e9ges mell\u00e9khat\u00e1st, gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1st vagy figyelmeztet\u00e9st. K\u00e9rj\u00fck, konzult\u00e1ljon orvos\u00e1val, \u00e9s besz\u00e9lje meg minden k\u00e9rd\u00e9s\u00e9t b\u00e1rmilyen betegs\u00e9ggel vagy gy\u00f3gyszerrel kapcsolatban. C\u00e9lunk a beteg-orvos kapcsolat t\u00e1mogat\u00e1sa, nem pedig helyettes\u00edt\u00e9se.<\/p>\n

Gyakran Ism\u00e9telt K\u00e9rd\u00e9sek<\/h2>\n

How does Lamivir work?<\/h3>\n

Lamivir is an antiretroviral that suppresses HIV replication; it is used as part of a multi-drug combination regimen, never as monotherapy. The mechanism, dose-by-indication tables, and contraindication list above give the molecule-specific clinical detail.<\/p>\n

How quickly does Lamivir work?<\/h3>\n

a v\u00edrusterhel\u00e9s cs\u00f6kken\u00e9se fokozatos; jelent\u0151s cs\u00f6kken\u00e9s \u00e1ltal\u00e1ban 4\u201312 h\u00e9ten bel\u00fcl l\u00e1that\u00f3 k\u00f6vetkezetes adagol\u00e1s mellett. Olvassa el az indik\u00e1ci\u00f3-specifikus adagol\u00e1si r\u00e9szt fent, amely az \u00d6n eset\u00e9re vonatkoz\u00f3 \u00fctemtervet tartalmazza.<\/p>\n

Mik a leggyakoribb mell\u00e9khat\u00e1sok?<\/h3>\n

A mell\u00e9khat\u00e1si profil a molekul\u00e1t\u00f3l \u00e9s az adagt\u00f3l f\u00fcgg. A fenti klinikai r\u00e9sz felsorolja a gyakori, alkalmi \u00e9s ritka mell\u00e9khat\u00e1sokat, valamint azon figyelmeztet\u0151 jeleket, amelyek azonnali orvosi fel\u00fclvizsg\u00e1latot ig\u00e9nyelnek.<\/p>\n

Can I take Lamivir with food or alcohol?<\/h3>\n

Az \u00e9tel- \u00e9s alkoholinterakci\u00f3k molekul\u00e1nk\u00e9nt v\u00e1ltoznak. Ellen\u0151rizze a fenti gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1si t\u00e1bl\u00e1zatot, amely tartalmazza az \u00e9telekre, alkoholra \u00e9s egyidej\u0171 gy\u00f3gyszerekre vonatkoz\u00f3 szab\u00e1lyokat.<\/p>\n

Mit tegyek, ha kihagyok egy adagot?<\/h3>\n

\u00c1ltal\u00e1ban vegye be a kihagyott adagot, amint esz\u00e9be jut, kiv\u00e9ve, ha k\u00f6zel van a k\u00f6vetkez\u0151 tervezett adaghoz, ebben az esetben hagyja ki \u2013 soha ne dupl\u00e1zza meg az adagot. Egyes molekul\u00e1knak saj\u00e1tos szab\u00e1lyai vannak; a fenti d\u00f3zisoz\u00e1si r\u00e9sz jelzi, hogy ez a gy\u00f3gyszer tartalmaz-e nem szabv\u00e1nyos kihagyott adag kezel\u00e9si utas\u00edt\u00e1st.<\/p>\n

Where can I order Lamivir from MedsBase?<\/h3>\n

MedsBase ships Lamivir discreetly worldwide from a WHO-GMP certified manufacturer. Card payments are processed through a regulated crypto on-ramp \u2014 your bank statement shows the processor name (a regulated card-payment processor), never “MedsBase” or any medication name. Every order is covered by our 20-business-day Reshipment Assurance.<\/p>\n

Patients transitioning from lamivudine-based regimens such as Lamivir<\/a> to PrEP protocols may be prescribed Tenvir EM (tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg)<\/a>, the preferred dual NRTI backbone in current WHO HIV prevention guidelines combining TDF with emtricitabine.<\/p>\n

Lamivir delivers lamivudine alone as a single NRTI; for HIV pre-exposure prophylaxis (PrEP), the standard fixed-dose combination is Ricovir-EM (tenofovir DF 300 mg + emtricitabin 200 mg)<\/a> \u2014 the tenofovir\/FTC backbone matches the iPrEx and Partners-PrEP trial regimens.<\/p>\n

<\/p>\n

Kapcsol\u00f3d\u00f3 alternat\u00edv\u00e1k<\/h3>\n

Egy\u00e9b term\u00e9kek a Kr\u00f3nikus betegs\u00e9gek<\/strong> v\u00e1s\u00e1rl\u00f3k \u00e1ltal szint\u00e9n megtekintett term\u00e9kek:<\/p>\n